Saajida Mahomed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saajida Mahomed has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Anikie Mathoma
College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
11 shared publications - Benn Sartorius
The University of Queensland
11 shared publications - Jacqueline Van Wyk
Department of Health Sciences Education, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
4 shared publications - Moherndran Archary
Victoria Mxenge Hospital, Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa
4 shared publications - Anesu Marume
University of Zimbabwe
3 shared publications Prashini Moodley
Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa
3 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Mortality Ratios (ASMRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Mortality Ratios (ASMRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Mortality Ratios (SMRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Mortality Ratios (SMRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Incidence Ratios (SIRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Incidence Ratios (SIRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Incidence Rates (ASIRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Incidence Rates (ASIRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background:Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion.Methods:We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer.Results:We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma.Conclusions:The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment.Impact:Our results will contribute to the National Cancer Control Plan development.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background:Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion.Methods:We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer.Results:We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma.Conclusions:The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment.Impact:Our results will contribute to the National Cancer Control Plan development.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Multivariable imputed ASIR and ASMR.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Multivariable imputed ASIR and ASMR.
- Open Access
- 3 April 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (5)
Trends in all-cause mortality after cancer diagnosis among people with and without HIV in Botswana, 1990–2021
Purpose: With a high HIV adult prevalence, the burden of cancer in Botswana has surged over the years, posing a significant threat for people living with HIV (PLWH). While HIV/AIDS-related deaths have declined due to effective antiretroviral therapy (ART), PLWH remain at elevated risk for cancer and related mortality. We aimed to evaluate all-cause mortality after cancer diagnosis among people with and without HIV in Botswana. Methods: We included adults aged ≥ 18 years who were reported in the national cancer registry between 1990 and 2021. The crude, age-standardized mortality (ASMR) rates per 100,000 and standardized mortality ratios (SMRs) were calculated. We determined time trends using generalized linear regression, assuming a Poisson distribution. Results: Over 30 years, 27,726 cancer cases and 9,609 deaths were reported. Of all the deaths, 4,548 (47.3%) were among PLWH, 1,183 (12.3%) among people without HIV, and 3,878 (40.4%) among people with unknown HIV status. Compared with people without HIV, the ASMRs for PLWH were higher and increased significantly from 1990 to 2021 (from 12.5 to 297.9 per 100,000, respectively; p-trend < 0.001) versus people without HIV (from 0.4 to 7.3 per 100,000, respectively; p-trend = 0.006). Further, mortality rates rose among PLWH who had AIDS-defining cancers (ADCs), non-AIDS-defining cancers (NADCs), breast and cervical cancers ( p-trend < 0.001). Although the SMRs for all ADCs and most NADCs sub-types declined after ART roll-out, in the late post-ART period, these were in excess among PLWH. Conclusion: Increasing trends and excess mortality among PLWH with cancer suggest a greater need for targeted screening strategies, and the provision of access to timely HIV and cancer treatment.
- 3 April 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (5)
Open AccessTrends in all-cause mortality after cancer diagnosis among people with and without HIV in Botswana, 1990–2021
Purpose: With a high HIV adult prevalence, the burden of cancer in Botswana has surged over the years, posing a significant threat for people living with HIV (PLWH). While HIV/AIDS-related deaths have declined due to effective antiretroviral therapy (ART), PLWH remain at elevated risk for cancer and related mortality. We aimed to evaluate all-cause mortality after cancer diagnosis among people with and without HIV in Botswana. Methods: We included adults aged ≥ 18 years who were reported in the national cancer registry between 1990 and 2021. The crude, age-standardized mortality (ASMR) rates per 100,000 and standardized mortality ratios (SMRs) were calculated. We determined time trends using generalized linear regression, assuming a Poisson distribution. Results: Over 30 years, 27,726 cancer cases and 9,609 deaths were reported. Of all the deaths, 4,548 (47.3%) were among PLWH, 1,183 (12.3%) among people without HIV, and 3,878 (40.4%) among people with unknown HIV status. Compared with people without HIV, the ASMRs for PLWH were higher and increased significantly from 1990 to 2021 (from 12.5 to 297.9 per 100,000, respectively; p-trend < 0.001) versus people without HIV (from 0.4 to 7.3 per 100,000, respectively; p-trend = 0.006). Further, mortality rates rose among PLWH who had AIDS-defining cancers (ADCs), non-AIDS-defining cancers (NADCs), breast and cervical cancers ( p-trend < 0.001). Although the SMRs for all ADCs and most NADCs sub-types declined after ART roll-out, in the late post-ART period, these were in excess among PLWH. Conclusion: Increasing trends and excess mortality among PLWH with cancer suggest a greater need for targeted screening strategies, and the provision of access to timely HIV and cancer treatment.
- 24 March 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (6) , 921-933
Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background: Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion. Methods: We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer. Results: We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma. Conclusions: The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment. Impact: Our results will contribute to the National Cancer Control Plan development.
- 24 March 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (6) , 921-933
Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background: Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion. Methods: We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer. Results: We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma. Conclusions: The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment. Impact: Our results will contribute to the National Cancer Control Plan development.
- Open Access
- 1 January 2026
- Published by AOSIS in African Journal of Primary Health Care & Family Medicine
- Vol. 18 (1) , 8
Maternal common mental disorder symptoms and child nutritional outcomes: The role of caregiving practices among children aged 6–59 months
Background: Maternal common mental disorders (CMDs) remain under recognised in many low-income countries, and these can compromise caregiving capacity during early childhood. Evidence linking maternal CMD symptoms to caregiving practices and child nutritional outcomes in Zimbabwe and similar settings remains limited. Aim: This study examined associations between maternal CMD symptoms, caregiving practices and nutritional outcomes among young children in Zimbabwe. Setting: The study was conducted in the Manicaland and Matabeleland South provinces of Zimbabwe. Methods: A secondary analysis of data from a household-based matched case-control study involving mother–child dyads attending primary health facilities was conducted. Maternal CMD symptoms were assessed using the Shona Symptom Questionnaire (SSQ 14) and analysed as a continuous variable. Multivariable logistic regression models were used to examine associations between maternal CMD symptoms and caregiving and child nutritional outcomes, adjusting for maternal, child and household covariates. Results: The prevalence of probable maternal CMD was 34.0% (95% confidence interval: 29.4–38.9). Higher maternal CMD symptom scores were associated with lower odds of antenatal care attendance, incomplete child vaccination and reduced uptake of vitamin A supplementation. Higher CMD symptoms were also associated with increased odds of early weaning, childhood stunting and childhood wasting. Conclusion: Maternal CMD symptoms were associated with diminished caregiving practices and adverse child nutritional outcomes. Integrating maternal mental health screening and support into routine maternal and child health services may improve child health and nutrition outcomes. Contribution: This study provides evidence linking maternal CMD symptoms with caregiving practices and child nutritional outcomes in a low-resource setting where such evidence remains limited.
- 1 January 2026
- Published by AOSIS in African Journal of Primary Health Care & Family Medicine
- Vol. 18 (1) , 8
Open AccessMaternal common mental disorder symptoms and child nutritional outcomes: The role of caregiving practices among children aged 6–59 months
Background: Maternal common mental disorders (CMDs) remain under recognised in many low-income countries, and these can compromise caregiving capacity during early childhood. Evidence linking maternal CMD symptoms to caregiving practices and child nutritional outcomes in Zimbabwe and similar settings remains limited. Aim: This study examined associations between maternal CMD symptoms, caregiving practices and nutritional outcomes among young children in Zimbabwe. Setting: The study was conducted in the Manicaland and Matabeleland South provinces of Zimbabwe. Methods: A secondary analysis of data from a household-based matched case-control study involving mother–child dyads attending primary health facilities was conducted. Maternal CMD symptoms were assessed using the Shona Symptom Questionnaire (SSQ 14) and analysed as a continuous variable. Multivariable logistic regression models were used to examine associations between maternal CMD symptoms and caregiving and child nutritional outcomes, adjusting for maternal, child and household covariates. Results: The prevalence of probable maternal CMD was 34.0% (95% confidence interval: 29.4–38.9). Higher maternal CMD symptom scores were associated with lower odds of antenatal care attendance, incomplete child vaccination and reduced uptake of vitamin A supplementation. Higher CMD symptoms were also associated with increased odds of early weaning, childhood stunting and childhood wasting. Conclusion: Maternal CMD symptoms were associated with diminished caregiving practices and adverse child nutritional outcomes. Integrating maternal mental health screening and support into routine maternal and child health services may improve child health and nutrition outcomes. Contribution: This study provides evidence linking maternal CMD symptoms with caregiving practices and child nutritional outcomes in a low-resource setting where such evidence remains limited.